Regulation of Controlled Substances and Reproductive Health
This Viewpoint reviews the US legal landscape for regulation of drugs with the potential for addiction, the pharmacology of mifepristone and misoprostol, evidence demonstrating their lack of dependency, and the consequences of 2024 policy changes in Louisiana state law.
This Viewpoint reviews the US legal landscape for regulation of drugs with the potential for addiction, the pharmacology of mifepristone and misoprostol, evidence demonstrating their lack of dependency, and the consequences of 2024 policy changes in Louisiana state law.
